ConductScience.org, home

Trial · NCT07909148

Parastomal Hernia at 1 and 3 Years: Radiological Incidence, Progression, and Impact on Quality of Life

NCT07909148, Recruiting, Region Skane

3 sourcestrials-2026-11-12-0.5.0

Download JSON
Cite this record

ConductScience Library. Parastomal Hernia at 1 and 3 Years: Radiological Incidence, Progression, and Impact on Quality of Life. Trials, record NCT07909148. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07909148

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
Parastomal Hernia at 1 and 3 Years: Radiological Incidence, Progression, and Impact on Quality of Life
NCT number
NCT07909148
Status
Recruiting
Enrollment
135 participants, estimated
Lead sponsor
Region Skane
Conditions
Parastomal Hernia, Colorectal Cancer (Diagnosis)
Interventions
Routine Surveillance Computed Tomography (CT)
First posted
2026-11-02
Last updated
2026-11-02

Source ClinicalTrials.gov

Registered outcomes7

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryMean Difference in Total Colostomy Impact Score (CIS) at 3 Years3 years post-surgery
The mean difference in total Colostomy Impact Score (CIS) between patients with and without a radiologically confirmed parastomal hernia at the 3-year follow-up. The CIS is a validated questionnaire with a total score ranging from 0 to 38, where higher scores indicate worse quality of life/greater symptom burden (scores 0-9: minor impact, 10-38: major impact).
SecondaryMean Difference in Total Colostomy Impact Score (CIS) at 1 Year1 year post-surgeryThe mean difference in total Colostomy Impact Score (CIS) between patients with and without a radiologically confirmed parastomal hernia at the 1-year follow-up.
SecondaryMean Difference in EQ-5D-5L Index Values at 1 Year1 year post-surgery
The mean difference in EQ-5D-5L index values between patients with and without a radiologically confirmed parastomal hernia at the 1-year follow-up. The index score ranges from 0 (representing death) to 1 (representing full health), with negative values for states worse than death; higher scores indicate better health-related quality of life.
SecondaryLongitudinal Change in Generic Quality of Life (EQ-5D-5L Index)From 1 year to 3 years post-surgery
The longitudinal change in the EQ-5D-5L index value for the total cohort between the 1-year and 3-year follow-ups. The score ranges from 0 to 1, where higher scores indicate better health-related quality of life.
SecondaryIncidence of Parastomal Hernia on CT Scans1 year and 3 years post-surgeryThe incidence of parastomal hernia at 1 and 3 years post-stoma creation, diagnosed by standardized review of routine oncological follow-up CT scans.
SecondaryRate of Radiological Parastomal Hernia ProgressionFrom 1 year to 3 years post-surgeryThe rate of hernia progression between the 1-year and 3-year follow-ups, defined by new hernia development, increase in fascial defect size, or change in European Hernia Society (EHS) classification.
SecondaryDiagnostic Correlation Between Patient-Reported Suspicion and Radiological Hernia1 year post-surgeryThe correlation between patient-reported suspicion of a hernia and radiologically confirmed parastomal hernia at the 1-year follow-up.

Outcomes0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

None in this release.

Results by group0

Each measurement the trial posted, group by group, in the words and numbers it posted.

None in this release.

Participant flow0

How many started, completed or left each group, period by period.

None in this release.

Adverse events0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

None in this release.

Adverse event totals0

The totals the trial posted for each group.

None in this release.

Papers0

The papers the trial lists on ClinicalTrials.gov.

None in this release.

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

None in this release.

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Data dates

The day each source was copied for this release.

ClinicalTrials.gov
2026-11-12
ClinicalTrials.gov
Results, from AACT
2026-03-23
AACT
NIH grant links
2026-11-13
NIH RePORTER

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT07909148

GET https://conductscience.org/api/trials/v1/NCT07909148/registered